Table 5 Drug-likeness of newly designed EGFR inhibitors
From: Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors
Entry | MW | WLOGP | No. of H-bond donors | No. of H-bond acceptors | RO5 violations | Synthetic accessibility |
|---|---|---|---|---|---|---|
SDD1 | 673.08 | 8.03 | 2 | 10 | 2 | 4.25 |
SDD2 | 670.11 | 4.06 | 3 | 9 | 1 | 4.36 |
SDD3 | 688.1 | 4.1 | 3 | 10 | 1 | 4.36 |
SDD4 | 706.09 | 8.66 | 3 | 10 | 2 | 4.37 |
SDD5 | 739 | 8.85 | 3 | 9 | 2 | 4.33 |
SDD6 | 722.54 | 8.76 | 3 | 10 | 2 | 4.34 |
Gefitinib | 446.9 | 4.32 | 1 | 7 | 0 | 3.26 |